Literature DB >> 18384441

Nail and periungual toxicity following capecitabine therapy.

Mario Vaccaro, Olga Barbuzza, Fabrizio Guarneri, Biagio Guarneri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18384441      PMCID： PMC2492910          DOI： 10.1111/j.1365-2125.2008.03174.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Onychomadesis and onycholysis associated with capecitabine.

Authors:  G Y Chen; Y H Chen; M M Hsu; C J Tsao; W C Chen
Journal:  Br J Dermatol       Date:  2001-09       Impact factor: 9.302

2.  Pyogenic granuloma-like lesions during capecitabine therapy.

Authors:  V Piguet; L Borradori
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

Review 3.  Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases.

Authors:  G-Y Chen; T-W Chang; W-C Chen
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

Review 4.  Drug reactions affecting the nail unit: diagnosis and management.

Authors:  Bianca Maria Piraccini; Matilde Iorizzo
Journal:  Dermatol Clin       Date:  2007-04       Impact factor: 3.478

Review 5.  Nail toxicity associated with epidermal growth factor receptor inhibitor therapy.

Authors:  Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2006-12-04       Impact factor: 11.527

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 7.  Capecitabine: a review.

Authors:  Christine M Walko; Celeste Lindley
Journal:  Clin Ther       Date:  2005-01       Impact factor: 3.393

8.  Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.

Authors:  G P Stathopoulos; J Koutantos; H Lazaki; S K Rigatos; J Stathopoulos; G Deliconstantinos
Journal:  Anticancer Res       Date:  2007 May-Jun       Impact factor: 2.480

9.  Taxane-induced nail changes: incidence, clinical presentation and outcome.

Authors:  A M Minisini; A Tosti; A F Sobrero; M Mansutti; B M Piraccini; C Sacco; F Puglisi
Journal:  Ann Oncol       Date:  2003-02       Impact factor: 32.976

10.  Onycholysis with the appearance of a "sunset" secondary to capecitabine.

Authors:  Kimberly L Maino; Christopher Norwood; Mitchell E Stashower
Journal:  Cutis       Date:  2003-09
  10 in total
  2 in total

1.  Compound mucocutaneous adverse effects of oral capecitabine in a patient.

Authors:  Hyacinth Peter Pinto; Ramesh M Bhat; Dinesh Shet; Sukumar Dandekeri
Journal:  Indian Dermatol Online J       Date:  2014-07

Review 2.  Onychomadesis associated with chemotherapy: case report and mini literature review.

Authors:  Ang Li; Yanqiong Li; Lingzhi Ge; Ping Li; Wenfei Li
Journal:  Drug Des Devel Ther       Date:  2017-08-14       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.